BC Extra | Jul 10, 2019
Clinical News

Michael Becker, patient advocate and biotech exec, dies at 50

Michael Becker, a former biotech entrepreneur and author who became a fierce patient advocate in his final years, passed away from metastatic HPV-related cancer. He was 50. Becker was president, CEO, CFO and director for...
BioCentury | Sep 7, 2017
Strategy

What if you build, but they don’t come

Vaccination is widely considered one of the greatest medical achievements of modern civilization. Diseases that were commonplace less than a generation ago, such as polio, smallpox and diphtheria, are now increasingly rare because of vaccines....
BioCentury | Nov 15, 2010
Finance

Spreading through China

Infinity Group has started investing out of six new funds, each of which is based in a different Chinese city. Infinity now manages 11 funds, nine of them in China. The funds are putting money...
BC Innovations | Mar 25, 2010
Distillery Therapeutics

Indication: Infectious disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Infectious disease Leishmaniasis Receptor tyrosine kinase (RTK) Studies in mice suggest that RTK inhibitors could boost the immune response to help treat Leishmaniasis infection. In Leishmania...
BC Innovations | Mar 4, 2010
Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Cancer Protein kinase B (PKB; Akt) In vitro and mouse studies suggest that a class of selective PKB inhibitors could help treat cancer. In vitro,...
BioCentury | Dec 8, 2008
Regulation

Vouching for Coartem

FDA apparently convened last week's advisory committee meeting on Coartem artemether/lumefantrine from Novartis AG to address political and public relations issues associated with the Priority Review voucher program for tropical diseases. Unlike at most advisory...
BioCentury | Dec 8, 2008
Regulation

Tropical diseases pipeline

Tropical diseases pipeline Company Product Indication Status Novartis (NYSE:NVS; SWX:NOVN) Coartem artemether (A)/lumefantrine Malaria Approved ex-U.S.; under review in U.S. Crucell (Euronext:CRXL; NASDAQ:CRXL) Dukoral vaccine Prevent cholera Approved ex-U.S. Paladin Labs (TSX:PLB) Impavido miltefosine Leishmaniasis...
BC Week In Review | Sep 15, 2008
Clinical News

Xyfid uracil regulatory update

FDA notified VioQuest that its topical Xyfid 1% uracil to treat dermatoses would be regulated as a drug rather than a device, meaning a marketing application will be reviewed by the Center for Drug Evaluation...
BC Week In Review | Aug 18, 2008
Company News

Arno management update

Arno Therapeutics Inc. (OTCBB:ARNI), Fairfield, N.J.   Business: Cancer   Hired: Brian Lenz as CFO, formerly CFO and treasurer of VioQuest Pharmaceuticals Inc.  ...
BC Week In Review | Jul 28, 2008
Company News

VioQuest management update

VioQuest Pharmaceuticals Inc. (OTCBB:VOQP), Basking Ridge, N.J.   Business: Cancer, Chemistry, Supply/Service   Hired: Christopher Schnittker as VP and CFO, formerly SVP and CFO at Micromet Inc. ; he replaces Brian Lenz, who resigned  ...
Items per page:
1 - 10 of 55
BC Extra | Jul 10, 2019
Clinical News

Michael Becker, patient advocate and biotech exec, dies at 50

Michael Becker, a former biotech entrepreneur and author who became a fierce patient advocate in his final years, passed away from metastatic HPV-related cancer. He was 50. Becker was president, CEO, CFO and director for...
BioCentury | Sep 7, 2017
Strategy

What if you build, but they don’t come

Vaccination is widely considered one of the greatest medical achievements of modern civilization. Diseases that were commonplace less than a generation ago, such as polio, smallpox and diphtheria, are now increasingly rare because of vaccines....
BioCentury | Nov 15, 2010
Finance

Spreading through China

Infinity Group has started investing out of six new funds, each of which is based in a different Chinese city. Infinity now manages 11 funds, nine of them in China. The funds are putting money...
BC Innovations | Mar 25, 2010
Distillery Therapeutics

Indication: Infectious disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Infectious disease Leishmaniasis Receptor tyrosine kinase (RTK) Studies in mice suggest that RTK inhibitors could boost the immune response to help treat Leishmaniasis infection. In Leishmania...
BC Innovations | Mar 4, 2010
Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Cancer Protein kinase B (PKB; Akt) In vitro and mouse studies suggest that a class of selective PKB inhibitors could help treat cancer. In vitro,...
BioCentury | Dec 8, 2008
Regulation

Vouching for Coartem

FDA apparently convened last week's advisory committee meeting on Coartem artemether/lumefantrine from Novartis AG to address political and public relations issues associated with the Priority Review voucher program for tropical diseases. Unlike at most advisory...
BioCentury | Dec 8, 2008
Regulation

Tropical diseases pipeline

Tropical diseases pipeline Company Product Indication Status Novartis (NYSE:NVS; SWX:NOVN) Coartem artemether (A)/lumefantrine Malaria Approved ex-U.S.; under review in U.S. Crucell (Euronext:CRXL; NASDAQ:CRXL) Dukoral vaccine Prevent cholera Approved ex-U.S. Paladin Labs (TSX:PLB) Impavido miltefosine Leishmaniasis...
BC Week In Review | Sep 15, 2008
Clinical News

Xyfid uracil regulatory update

FDA notified VioQuest that its topical Xyfid 1% uracil to treat dermatoses would be regulated as a drug rather than a device, meaning a marketing application will be reviewed by the Center for Drug Evaluation...
BC Week In Review | Aug 18, 2008
Company News

Arno management update

Arno Therapeutics Inc. (OTCBB:ARNI), Fairfield, N.J.   Business: Cancer   Hired: Brian Lenz as CFO, formerly CFO and treasurer of VioQuest Pharmaceuticals Inc.  ...
BC Week In Review | Jul 28, 2008
Company News

VioQuest management update

VioQuest Pharmaceuticals Inc. (OTCBB:VOQP), Basking Ridge, N.J.   Business: Cancer, Chemistry, Supply/Service   Hired: Christopher Schnittker as VP and CFO, formerly SVP and CFO at Micromet Inc. ; he replaces Brian Lenz, who resigned  ...
Items per page:
1 - 10 of 55